Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme
The DOI matches its Crossref record.
Abstract
Aim To measure the cumulative incidence of any retinopathy, maculopathy and sight‐threatening diabetic retinopathy (STDR), and calculate optimal screening intervals by retinopathy grade at baseline for patients with Type 1 diabetes attending an established systematic retinal screening programme. Methods All patients with Type 1 diabetes registered with enrolled general practitioners, excluding only those attending an ophthalmologist, were studied if retinopathy data was available at baseline and at least one further screen event. Screening utilized non‐stereoscopic 3‐field mydriatic photography and modified Wisconsin grading. STDR was defined as moderate pre‐proliferative retinopathy or greater and/or significant maculopathy in any eye. Results Patients (n = 501) underwent 2742 screen events. Cumulative incidence of STDR in patients without baseline retinopathy was 0.3% (95% CI 0.0–0.9) at 1 year, rising to 3.9% (1.4–5.4) at 5 years. Rates of progression to STDR in patients with background and mild pre‐proliferative retinopathy at 1 year were 3.6% (0.5–6.6) and 13.5% (4.2–22.7), respectively. Progression to STDR was greater in patients with a higher grade of baseline retinopathy (P = 0.001) or a longer disease duration (P = 0.003). For a 95% likelihood of remaining free of STDR, mean screening intervals by baseline status were: no retinopathy 5.7 (95% CI 3.5–7.6) years, background 1.3 (0.4–2.0) years and mild pre‐proliferative 0.4 (0–0.8) years. Conclusions Screening at 2–3 year intervals, rather than annually, for patients without retinopathy in Type 1 diabetes is feasible because of the low risk of progression to STDR, and may result in significant cost savings for a screening programme. Patients with higher grades of retinopathy require screening at least annually or more frequent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
The global burden of diabetes and its complications: an emerging pandemic
Susan van, D., Beulens, J. W. J., Yvonne T. van der, S., Grobbee, D. E., & Nealb, B. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000368191.86614.5a · Cited by 874
Leveraging uncertainty information from deep neural networks for disease detection
Leibig, C., Allken, V., Ayhan, M. S., Berens, P., & Wahl, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-17876-z · Cited by 510
Diabetic retinopathy screening: a systematic review of the economic evidence
Jones, S., & Edwards, R. T. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02870.x · Cited by 265
Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00560-z · Cited by 179
“Three studies presented data on the incidence of sight threatening DR (STDR) or referable DR (RDR) [46, 66, 68, 70].”
Background
Metadata
- Authors
- Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2003-08-19
- Volume
- 20
- Issue
- 9
- Pages
- 758-765
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1953868286
- Cited by
- 103
- References
- 0
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme. https://app.cochat.ai/papers/10.1046/j.1464-5491.2003.01035.x
- The paper
- Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P. (2003). Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2003.01035.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.